How to buy ESSA Pharma stock (EPIX)

ESSA Pharma is a biotechnology business based in the US. ESSA Pharma shares (EPIX) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $1.75 – an increase of 9.38% over the previous week. ESSA Pharma employs 50 staff and has a market cap (total outstanding shares value) of 0.00.

Our top picks for where to buy ESSA Pharma stock

Buy ESSA Pharma stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

ESSA Pharma stock price (NASDAQ: EPIX)

Use our graph to track the performance of EPIX stocks over time.

ESSA Pharma shares at a glance

• Key figures

Information last updated 2024-12-26.

Latest market close	$1.75
52-week range	$1.40 - $11.67
50-day moving average more info button	$2.74
200-day moving average more info button	$5.33
Wall St. target price	$9.18
PE ratio more info button	N/A
Dividend yield more info button	N/A
Earnings per share (TTM) more info button	$-0.64

Is it a good time to buy ESSA Pharma stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

ESSA Pharma price performance over time

Historical closes compared with the close of $1.61 from 2024-12-24

1 week (2024-12-20)	0.63%
1 month (2024-11-27)	-10.06%
3 months (2024-09-27)	-75.00%
6 months (2024-06-28)	-69.39%

1 year (2023-12-28)	-77.29%
2 years (2022-12-28)	-36.11%
3 years (2021-12-28)	13.72
5 years (2019-12-27)	5.58

ESSA Pharma financials

Gross profit TTM	$0
Return on assets TTM	-14.79%
Return on equity TTM	-19.83%
Profit margin	0%
Book value	$2.90
Market Capitalization more info button	$71.5 million

TTM: trailing 12 months

ESSA Pharma share dividends

We're not expecting ESSA Pharma to pay a dividend over the next 12 months.

Have ESSA Pharma's shares ever split?

ESSA Pharma's shares were split on a 1:20 basis on 24 April 2018 . So if you had owned 20 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your ESSA Pharma shares – just the quantity. However, indirectly, the new 1900% higher share price could have impacted the market appetite for ESSA Pharma shares which in turn could have impacted ESSA Pharma's share price.

ESSA Pharma share price volatility

Over the last 12 months, ESSA Pharma's shares have ranged in value from as little as $1.4 up to $11.67. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while ESSA Pharma's is 1.84. This would suggest that ESSA Pharma's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

ESSA Pharma overview

ESSA Pharma Inc. , a clinical stage pharmaceutical company, focuses the development of small molecule drugs for the treatment of prostate cancer. The company's lead candidate EPI-7386, an androgen receptor based resistance mechanisms that develop in patients with castration-resistant prostate cancer and metastatic castration-resistant prostate cancer. It has collaboration agreements with Bayer Consumer Care AG; Janssen Research & Development, LLC; and Astellas Pharma Inc. ESSA Pharma Inc. was incorporated in 2009 and is headquartered in Vancouver, Canada. .

Frequently asked questions

null
What percentage of ESSA Pharma is owned by insiders or institutions?
Currently 2.263% of ESSA Pharma shares are held by insiders and 81.188% by institutions. How many people work for ESSA Pharma?
Latest data suggests 50 work at ESSA Pharma. When does the fiscal year end for ESSA Pharma?
ESSA Pharma's fiscal year ends in September. Where is ESSA Pharma based?
ESSA Pharma's address is: 999 West Broadway, Vancouver, BC, Canada, V5Z 1K5 What is ESSA Pharma's ISIN number?
ESSA Pharma's international securities identification number is: CA29668H7085 What is ESSA Pharma's CUSIP number?
ESSA Pharma's Committee on Uniform Securities Identification Procedures number is: 29668H708